var data={"title":"Group C and group G streptococcal infection","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Group C and group G streptococcal infection</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/contributors\" class=\"contributor contributor_credentials\">Michael R Wessels, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/contributors\" class=\"contributor contributor_credentials\">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Mar 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 08, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H30585770\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The designations &quot;group C <em>Streptococcus</em>&quot; (GCS) and &quot;group G <em>Streptococcus</em>&quot; (GGS) are used by clinical microbiology laboratories to denote clinical isolates of streptococci that react with Lancefield group C or G typing serum and, like <em>Streptococcus pyogenes </em>(group A <em>Streptococcus</em>), form large colonies on sheep blood agar, typically surrounded by a zone of beta-hemolysis (<a href=\"image.htm?imageKey=ID%2F68908\" class=\"graphic graphic_picture graphicRef68908 \">picture 1</a> and <a href=\"image.htm?imageKey=ID%2F102608\" class=\"graphic graphic_algorithm graphicRef102608 \">algorithm 1</a>).</p><p>GCS and GGS are normal commensal flora of the human upper airway and frequently are asymptomatic colonizers of the skin, gastrointestinal tract, and female genital tract. They are also implicated in mono- and polymicrobial infections of the skin and soft tissues, pharyngitis, bacteremia and endocarditis, septic arthritis and osteomyelitis, puerperal infections, and meningitis.</p><p>GCS and GGS of human origin are now considered to constitute a single subspecies, <em>Streptococcus dysgalactiae </em>subsp<em> equisimilis</em>. A comparison of the complete genome sequence of a clinical isolate of GGS <em>S. dysgalactiae </em>subsp<em> equisimilis</em> with that of other streptococcal species demonstrated it is most closely related to <em>S. pyogenes</em>, with 72 percent sequence similarity [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/1\" class=\"abstract_t\">1</a>]. <em>S. dysgalactiae </em>subsp<em> equisimilis</em> shares many virulence determinants with <em>S. pyogenes</em>, including the antiphagocytic M protein, streptolysin O, streptolysin S, streptokinase, and one or more pyrogenic exotoxins similar to those implicated in streptococcal toxic shock [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/1,2\" class=\"abstract_t\">1,2</a>].</p><p>GCS and GGS of animal origin are occasionally associated with human infection; these bacteria belong to distinct species. (See <a href=\"#H30585776\" class=\"local\">'Microbiology'</a> below.)</p><p>Streptococci in the <em>S. anginosus</em> or <em>S. milleri</em> group may also react with C or G typing sera, but these organisms are distinguished by the fact that they form small (&lt;0.5 mm) colonies on sheep blood agar. They are normally identified by diagnostic laboratories as belonging to the <em>S. anginosus</em> or <em>S. milleri</em> group, not as GCS or GGS. (See <a href=\"topic.htm?path=infections-due-to-the-streptococcus-anginosus-streptococcus-milleri-group\" class=\"medical medical_review\">&quot;Infections due to the Streptococcus anginosus (Streptococcus milleri) group&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H30585776\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A precise definition of the bacterial species encompassed by Lancefield serologic groups C and G has been elusive for two reasons. First, no single streptococcal species is uniquely identifiable via the expression of group C or group G antigen; this is in contrast with, for example, group B <em>Streptococcus</em>, which corresponds to a single species, <em>Streptococcus agalactiae</em>. Second, the taxonomy of the organisms identified as belonging to group C or G has been inconsistent and has evolved over time.</p><p>Beginning in the 1930s, the designation <em>Streptococcus equisimilis</em> was used for beta-hemolytic streptococci of human origin belonging to Lancefield group C. The designation <em>Streptococcus dysgalactiae</em> was used for alpha-hemolytic streptococci isolated from cows belonging to Lancefield group C. DNA homology studies in the 1980s indicated that both of these streptococci, in addition to large-colony streptococci of group G and L, belonged to a single species, <em>S. dysgalactiae</em>.</p><p>In 1996, it was proposed that the species be subdivided into two subspecies [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/3\" class=\"abstract_t\">3</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. dysgalactiae</em> subsp <em>equisimilis</em> corresponding to large-colony beta-hemolytic human isolates expressing Lancefield group C or G antigen</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. dysgalactiae</em> subsp <em>dysgalactiae</em> corresponding to large-colony variably hemolytic animal isolates expressing Lancefield group C or L antigen [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/3\" class=\"abstract_t\">3</a>]</p><p/><p>The vast majority of clinical isolates associated with human infection that are identified as group C or G streptococci belong to the former taxon, <em>S. dysgalactiae</em> subsp <em>equisimilis</em> [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/4\" class=\"abstract_t\">4</a>].</p><p>Various streptococci of animal origin also express the group C or G antigen and are occasionally implicated in human infection. Among group C streptococci, <em>Streptococcus equi</em> subsp <em>equi</em> and <em>S. equi</em> subsp <em>zooepidemicus</em> are associated primarily with horses, in which they cause, respectively, suppurative lymphadenitis (strangles) and respiratory infections [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/5\" class=\"abstract_t\">5</a>]. The group G <em>Streptococcus,</em> <em>S. canis,</em> is associated with several animal species, including dogs, cats, and cattle [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/4,6\" class=\"abstract_t\">4,6</a>].</p><p class=\"headingAnchor\" id=\"H30585782\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Because group C streptococci (GCS) and group G streptococci (GGS) represent normal human flora, infections due to these bacteria are not restricted by geographic locale or particular social or occupational activities. Several clinical case series have found GCS and GGS infections to be more common among older adults and in individuals with underlying chronic illness. The burden of invasive disease due to GCS and GGS is similar to that attributable to group A <em>Streptococcus</em> (<em>S. pyogenes</em>) [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/7\" class=\"abstract_t\">7</a>].</p><p>The incidence of invasive disease may be increasing: a retrospective review of bacteremia from two centers in Canada between 2007 and 2014 noted an increase in the proportion of bacteremias due to GCS (4 to 6 percent) and GGS (0.4 to 1.5 percent) [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/8\" class=\"abstract_t\">8</a>]. Another study reported the incidence of invasive infection due to GCS and GGS in western Norway increased between 1999 and 2013 from 1.4 per 100,000 to 6.3 per 100,000 [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/9\" class=\"abstract_t\">9</a>]. Genomic analysis of invasive isolates from both regions revealed that a limited number of clonal groups are responsible for the majority of cases, a finding that suggests emergence of a few particularly virulent clones of <em>S. dysgalactiae</em> subsp <em>equisimilis</em> may account for the increasing prevalence of bacteremia and other invasive disease syndromes [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/10,11\" class=\"abstract_t\">10,11</a>].</p><p>Zoonotic infections with <em>S. equi</em> subsp <em>zooepidemicus </em>have been reported occasionally in individuals with exposure to farm animals, especially horses, although not all human infections with this organism can be linked to animal contact [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/12,13\" class=\"abstract_t\">12,13</a>]. Several well-documented outbreaks of infection with <em>S. equi</em> subsp <em>zooepidemicus</em> have been attributed to ingestion of inadequately pasteurized dairy products, in some cases complicated by poststreptococcal glomerulonephritis [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/14-17\" class=\"abstract_t\">14-17</a>]. Rare cases of human infection with <em>S. canis</em> have been associated with household contact with dogs [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/18-20\" class=\"abstract_t\">18-20</a>].</p><p class=\"headingAnchor\" id=\"H30585788\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Group C streptococci (GCS) and group G streptococci (GGS) have been implicated in a wide variety of human infections: pharyngitis, a range of skin and soft tissue infections (including impetigo, infected ulcers, wound infections, cellulitis, and necrotizing soft tissue infection), bacteremia, endocarditis, septic arthritis, osteomyelitis, pleuropulmonary infections, peritonitis, intra-abdominal abscess, meningitis, puerperal sepsis, neonatal sepsis, and streptococcal toxic shock&ndash;like syndrome [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/21,22\" class=\"abstract_t\">21,22</a>].</p><p>While poststreptococcal glomerulonephritis has been reported as a sequel of infection with the animal-associated GCS <em>S. equi </em>subsp<em> zooepidemicus, </em>neither GCS nor GGS has been shown to trigger acute rheumatic fever. (See <a href=\"#H30585782\" class=\"local\">'Epidemiology'</a> above.)</p><p class=\"headingAnchor\" id=\"H30585794\"><span class=\"h2\">Bacteremia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>GCS and GGS together accounted for 30 percent of beta-hemolytic streptococcal bacteremia among adults in a hospital-based series [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/23\" class=\"abstract_t\">23</a>]. In a review of 88 cases of GCS bacteremia, the mean age was 45 years, and 19 percent were younger than 18 years of age [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/24\" class=\"abstract_t\">24</a>]. Underlying medical conditions were present in 74 percent, most commonly cardiovascular disease, malignancy, or immunosuppression. The most common sources of GCS bacteremia were thought to be the upper respiratory tract, gastrointestinal tract (including a cluster of cases due to <em>S. equi </em>subsp <em>zooepidemicus</em> from the consumption of unpasteurized milk), and skin sources, such as wounds, ulcers, and injection drug use.</p><p>Clinical syndromes associated with GCS bacteremia included endocarditis, meningitis, cutaneous infection, intra-abdominal infection, pneumonia, sinusitis, pharyngitis, epiglottitis, arthritis, osteomyelitis, mycotic aneurysm, fistula infection, genitourinary tract infection, and pericarditis. Mortality is approximately 25 percent [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/24,25\" class=\"abstract_t\">24,25</a>].</p><p>Case series of group G streptococcal bacteremia have described similar clinical features: advanced age, malignancy, diabetes, and alcohol use as underlying conditions; the skin as the most common source; and endocarditis and bone and joint infections as associated clinical syndromes [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/26-34\" class=\"abstract_t\">26-34</a>].</p><p class=\"headingAnchor\" id=\"H30585800\"><span class=\"h2\">Endocarditis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In some series of patients with invasive GCS or GGS infection, bacteremia has been associated with endocarditis in 25 to 50 percent of cases [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/24,28,35,36\" class=\"abstract_t\">24,28,35,36</a>]. Endocarditis has been reported both in patients with preexisting valvular disease and in patients with previously normal valves. Embolic complications are common and may be associated with large valvular vegetations. Some authors favor consideration of early valve replacement because of the risk of embolic events, especially stroke [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/37\" class=\"abstract_t\">37</a>].</p><p class=\"headingAnchor\" id=\"H30585806\"><span class=\"h2\">Arthritis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Septic arthritis is a relatively frequent presentation of invasive GCS or GGS infection, with or without detectable bacteremia [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/38-42\" class=\"abstract_t\">38-42</a>]. Patients are frequently older adults with underlying chronic illness, and there appears to be a male predominance. Preexisting arthritis and the presence of a prosthetic joint are common predisposing factors. The knee is involved most often; polyarticular infection occurs occasionally and should suggest the possibility of concomitant endocarditis.</p><p class=\"headingAnchor\" id=\"H30585812\"><span class=\"h2\">Skin and soft tissue infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>GCS and GGS have been implicated as a cause of skin and soft tissue infection, particularly in the setting of preexisting vascular or lymphatic compromise. Recurrent lower extremity cellulitis has been described after saphenous venectomy for coronary artery bypass surgery, sometimes in association with tinea pedis and colonization of the web space between the toes [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/43,44\" class=\"abstract_t\">43,44</a>]. Anal colonization may also be a source for recurrent infection [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/45\" class=\"abstract_t\">45</a>]. Recurrent GGS bacteremia occurred in 14 percent of patients in one series and was frequently associated with underlying lymphatic disorders [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/32\" class=\"abstract_t\">32</a>]. Necrotizing fasciitis similar to that caused by <em>S. pyogenes</em> has also been observed, in some cases associated with streptococcal toxic shock&ndash;like syndrome [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/22,46,47\" class=\"abstract_t\">22,46,47</a>].</p><p class=\"headingAnchor\" id=\"H30585818\"><span class=\"h2\">Pharyngitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Epidemic pharyngitis has been reported from foodborne infection with GCS or GGS, particularly in semiclosed populations such as military installations or schools [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/15,48,49\" class=\"abstract_t\">15,48,49</a>]. Dairy products, egg salad, and chicken salad have been implicated as sources. Respiratory outbreaks of GGS pharyngitis via person-to-person transmission have also been described [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/50\" class=\"abstract_t\">50</a>]. In contrast, the role of GCS and GGS in sporadic or endemic pharyngitis is controversial. Some studies have found higher rates of isolation of GCS or GGS in throat cultures of individuals with symptomatic pharyngitis compared with asymptomatic controls, whereas others have not [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/51-54\" class=\"abstract_t\">51-54</a>]. Thus, with the possible exception of a suspected outbreak, the isolation of GCS or GGS in a throat culture from a patient with pharyngitis is of uncertain significance. GCS and GGS are not detected by rapid antigen tests for GAS pharyngitis because they lack the group A antigen that is the target of these tests.</p><p class=\"headingAnchor\" id=\"H30585824\"><span class=\"h1\">DIAGNOSTIC EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diagnosis of infection due to group C streptococci (GCS) and group G streptococci (GGS) depends on identification of the organism in a culture from a clinical specimen. In general, a positive culture from a normally sterile site, such as blood, synovial fluid, or cerebrospinal fluid (CSF), can be considered definitive evidence of infection in the setting of a compatible clinical syndrome. The interpretation of positive cultures for GCS or GGS from the pharynx or from cutaneous sites such as open ulcers or wounds is less straightforward since asymptomatic colonization of the upper airway and skin also occurs.</p><p>Microbiologic identification of large-colony beta-hemolytic streptococci as GCS or GGS may be done by Lancefield serologic grouping. The use of <a href=\"topic.htm?path=bacitracin-drug-information\" class=\"drug drug_general\">bacitracin</a> sensitivity as a screening method to identify <em>S. pyogenes</em> may falsely identify GCS or GGS as <em>S. pyogenes,</em> since 15 percent of <em>S. dysgalactiae</em> subsp <em>equisimilis</em> isolates were susceptible to bacitracin in one study [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/4\" class=\"abstract_t\">4</a>].</p><p>Identification to the species or subspecies level is not routinely done in many clinical diagnostic laboratories but can be accomplished by a series of individual biochemical tests or commercially available biochemical test panels or by 16S and 23S ribosomal RNA gene sequencing [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/21,55\" class=\"abstract_t\">21,55</a>]. Helpful biochemical tests to distinguish GCS and GGS from other beta-hemolytic streptococci include a negative pyrrolidonyl arylamidase test (<em>S. pyogenes</em> is positive), negative hippurate test (<em>S. agalactiae</em> is positive), positive beta-D-glucuronidase test (<em>S. anginosus</em> group is negative), and negative Voges-Proskauer test (<em>S. anginosus</em> group is positive).</p><p>Isolates belonging to the <em>S. anginosus</em> or <em>S. milleri</em> group may express the Lancefield group C or G (or A or F) antigen but can be distinguished from large-colony GCS and GGS by their smaller colony size (&lt;0.5 mm), a negative beta-D-glucuronidase test, and a positive Voges-Proskauer test.</p><p class=\"headingAnchor\" id=\"H30585830\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Group C streptococci (GCS) and group G streptococci (GGS) are susceptible to beta-lactam antibiotics.</p><p>Penicillin is considered the drug of choice for treatment of GCS and GGS infections [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/21,56,57\" class=\"abstract_t\">21,56,57</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of GCS or GGS cellulitis consists of <a href=\"topic.htm?path=penicillin-g-intravenous-and-short-acting-intramuscular-drug-information\" class=\"drug drug_general\">penicillin G</a> 2 million units intravenously (IV) every 4 to 6 hours (for children: 50,000 <span class=\"nowrap\">units/kg/dose,</span> not to exceed adult dose).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of bacteremia, severe invasive soft tissue infection, endocarditis, osteomyelitis, or septic arthritis due to GCS or GGS consists of <a href=\"topic.htm?path=penicillin-g-intravenous-and-short-acting-intramuscular-drug-information\" class=\"drug drug_general\">penicillin G</a> 3 million units IV every 4 hours (for children: 75,000 <span class=\"nowrap\">units/kg/dose,</span> not to exceed adult dose).</p><p/><p>Third-generation cephalosporins are also highly active and are suitable alternative agents. Options include <a href=\"topic.htm?path=cefotaxime-drug-information\" class=\"drug drug_general\">cefotaxime</a> 2 g IV every 6 hours (for children: 50 <span class=\"nowrap\">mg/kg/dose</span> IV every 6 hours, not to exceed adult dose) or <a href=\"topic.htm?path=ceftriaxone-drug-information\" class=\"drug drug_general\">ceftriaxone</a> 2 g IV every 24 hours (for children: 50 <span class=\"nowrap\">mg/kg/dose</span> IV every 24 hours, not to exceed adult dose).</p><p>The duration of treatment should be tailored to clinical response and generally should be continued until at least three days after resolution of fever and other clinical signs. General guidelines are 7 to 10 days for cellulitis, 14 days for bacteremia, 14 to 28 days for severe invasive soft tissue infection, 28 to 42 days for osteomyelitis or septic arthritis, and 28 to 42 days for endocarditis.</p><p>Issues related to treatment of specific infections are discussed further separately. (See <a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis\" class=\"medical medical_review\">&quot;Antimicrobial therapy of native valve endocarditis&quot;</a> and <a href=\"topic.htm?path=necrotizing-soft-tissue-infections\" class=\"medical medical_review\">&quot;Necrotizing soft tissue infections&quot;</a>.)</p><p>For patients with a history of severe hypersensitivity reactions to beta-lactam antibiotics, <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">vancomycin</a> may be used. <a href=\"topic.htm?path=linezolid-drug-information\" class=\"drug drug_general\">Linezolid</a> and <a href=\"topic.htm?path=daptomycin-drug-information\" class=\"drug drug_general\">daptomycin</a> are active in vitro, but clinical experience in treating GCS and GGS infections with either agent is limited. The prevalence of resistance to macrolides is highly variable but has been as high as 15 to 25 percent in some areas and is sometimes associated with inducible <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> resistance [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/57-59\" class=\"abstract_t\">57-59</a>]. High-level resistance to fluoroquinolones has been described in a small percentage of clinical isolates [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/56,60\" class=\"abstract_t\">56,60</a>].</p><p>Treatment of pharyngitis when GCS or GGS has been isolated from a throat culture may be indicated in the setting of a point-source (eg, foodborne) outbreak or in sporadic cases in which clinical features suggest pyogenic bacterial infection (ie, fever, tonsillar exudates, tender cervical lymphadenopathy, and absence of cough or rhinorrhea) [<a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/61\" class=\"abstract_t\">61</a>]. The same regimens recommended for <em>S. pyogenes</em> are suitable for <span class=\"nowrap\">GCS/GGS</span> pharyngitis. However, <span class=\"nowrap\">GCS/GGS</span> pharyngitis is not known to trigger acute rheumatic fever; therefore, a treatment course of 5 days (rather than 10 days) is reasonable. (See <a href=\"topic.htm?path=treatment-and-prevention-of-streptococcal-pharyngitis\" class=\"medical medical_review\">&quot;Treatment and prevention of streptococcal pharyngitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H30585836\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Large-colony beta-hemolytic streptococci that express the Lancefield group C or G antigen are normal flora of the human respiratory and gastrointestinal and female genital tracts; they belong to a single subspecies, <em>Streptococcus dysgalactiae</em> subsp <em>equisimilis</em>. (See <a href=\"#H30585770\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Streptococci in the <em>S. anginosus </em>or<em> S.</em> <em>milleri</em> group may also react with C or G typing sera, but these organisms are distinguished from group C streptococci (GCS) and group G streptococci (GGS) by the fact that they form small (&lt;0.5 mm) colonies on blood agar and by distinct reactions in biochemical tests. (See <a href=\"#H30585770\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Streptococci associated with animals may also express the C or G antigens and are rare causes of human infection. Outbreaks of human infection with the GCS <em>S. equi </em>subsp <em>zooepidemicus</em> have been linked to ingestion of inadequately pasteurized dairy products. (See <a href=\"#H30585776\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical syndromes associated with GCS and GGS infection included bacteremia, endocarditis, septic arthritis, skin and soft tissue infections, and epidemic pharyngitis as well as a variety of other less common infection syndromes. (See <a href=\"#H30585788\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>GCS and GGS are universally susceptible to beta-lactam antibiotics, and penicillin is the treatment of choice for serious infection. (See <a href=\"#H30585830\" class=\"local\">'Treatment'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/1\" class=\"nounderline abstract_t\">Shimomura Y, Okumura K, Murayama SY, et al. Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS). BMC Genomics 2011; 12:17.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/2\" class=\"nounderline abstract_t\">Davies MR, McMillan DJ, Beiko RG, et al. Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin Infect Dis 2007; 44:1442.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/3\" class=\"nounderline abstract_t\">Vandamme P, Pot B, Falsen E, et al. Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. Int J Syst Bacteriol 1996; 46:774.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/4\" class=\"nounderline abstract_t\">Jensen A, Kilian M. Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes. J Clin Microbiol 2012; 50:113.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/5\" class=\"nounderline abstract_t\">Timoney JF. The pathogenic equine streptococci. Vet Res 2004; 35:397.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/6\" class=\"nounderline abstract_t\">Lacave G, Coutard A, Troch&eacute; G, et al. Endocarditis caused by Streptococcus canis: an emerging zoonosis? Infection 2016; 44:111.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/7\" class=\"nounderline abstract_t\">Broyles LN, Van Beneden C, Beall B, et al. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis 2009; 48:706.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/8\" class=\"nounderline abstract_t\">Schwartz IS, Keynan Y, Gilmour MW, et al. Changing trends in &beta;-hemolytic streptococcal bacteremia in Manitoba, Canada: 2007-2012. Int J Infect Dis 2014; 28:211.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/9\" class=\"nounderline abstract_t\">Oppegaard O, Mylvaganam H, Kittang BR. Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey. Clin Microbiol Infect 2015; 21:171.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/10\" class=\"nounderline abstract_t\">Lother SA, Demczuk W, Martin I, et al. Clonal Clusters and Virulence Factors of Group C and G Streptococcus Causing Severe Infections, Manitoba, Canada, 2012-2014. Emerg Infect Dis 2017; 23:1079.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/11\" class=\"nounderline abstract_t\">Oppegaard O, Mylvaganam H, Skrede S, et al. Emergence of a Streptococcus dysgalactiae subspecies equisimilis stG62647-lineage associated with severe clinical manifestations. Sci Rep 2017; 7:7589.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/12\" class=\"nounderline abstract_t\">Pelkonen S, Lindahl SB, Suomala P, et al. Transmission of Streptococcus equi subspecies zooepidemicus infection from horses to humans. Emerg Infect Dis 2013; 19:1041.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/13\" class=\"nounderline abstract_t\">Rajasekhar A, Clancy CJ. Meningitis due to group C Streptococcus: a case report and review of the literature. Scand J Infect Dis 2010; 42:571.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/14\" class=\"nounderline abstract_t\">Bordes-Ben&iacute;tez A, S&aacute;nchez-O&ntilde;oro M, Su&aacute;rez-Bord&oacute;n P, et al. Outbreak of Streptococcus equi subsp. zooepidemicus infections on the island of Gran Canaria associated with the consumption of inadequately pasteurized cheese. Eur J Clin Microbiol Infect Dis 2006; 25:242.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/15\" class=\"nounderline abstract_t\">Barnham M, Thornton TJ, Lange K. Nephritis caused by Streptococcus zooepidemicus (Lancefield group C). Lancet 1983; 1:945.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/16\" class=\"nounderline abstract_t\">Francis AJ, Nimmo GR, Efstratiou A, et al. Investigation of milk-borne Streptococcus zooepidemicus infection associated with glomerulonephritis in Australia. J Infect 1993; 27:317.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/17\" class=\"nounderline abstract_t\">Kuusi M, Lahti E, Virolainen A, et al. An outbreak of Streptococcus equi subspecies zooepidemicus associated with consumption of fresh goat cheese. BMC Infect Dis 2006; 6:36.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/18\" class=\"nounderline abstract_t\">Galp&eacute;rine T, Cazorla C, Blanchard E, et al. Streptococcus canis infections in humans: retrospective study of 54 patients. J Infect 2007; 55:23.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/19\" class=\"nounderline abstract_t\">Ohtaki H, Ohkusu K, Ohta H, et al. A case of sepsis caused by Streptococcus canis in a dog owner: a first case report of sepsis without dog bite in Japan. J Infect Chemother 2013; 19:1206.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/20\" class=\"nounderline abstract_t\">Lam MM, Clarridge JE 3rd, Young EJ, Mizuki S. The other group G Streptococcus: increased detection of Streptococcus canis ulcer infections in dog owners. J Clin Microbiol 2007; 45:2327.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/21\" class=\"nounderline abstract_t\">Brandt CM, Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis 2009; 49:766.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/22\" class=\"nounderline abstract_t\">Loubinoux J, Plainvert C, Collobert G, et al. Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010. J Clin Microbiol 2013; 51:2724.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/23\" class=\"nounderline abstract_t\">Schugk J, Harjola VP, Sivonen A, et al. A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period. Scand J Infect Dis 1997; 29:233.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/24\" class=\"nounderline abstract_t\">Bradley SF, Gordon JJ, Baumgartner DD, et al. Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis 1991; 13:270.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/25\" class=\"nounderline abstract_t\">Carmeli Y, Schapiro JM, Neeman D, et al. Streptococcal group C bacteremia. Survey in Israel and analytic review. Arch Intern Med 1995; 155:1170.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/26\" class=\"nounderline abstract_t\">Auckenthaler R, Hermans PE, Washington JA 2nd. Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis 1983; 5:196.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/27\" class=\"nounderline abstract_t\">Vartian C, Lerner PI, Shlaes DM, Gopalakrishna KV. Infections due to Lancefield group G streptococci. Medicine (Baltimore) 1985; 64:75.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/28\" class=\"nounderline abstract_t\">Venezio FR, Gullberg RM, Westenfelder GO, et al. Group G streptococcal endocarditis and bacteremia. Am J Med 1986; 81:29.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/29\" class=\"nounderline abstract_t\">Watsky KL, Kollisch N, Densen P. Group G streptococcal bacteremia. The clinical experience at Boston University Medical Center and a critical review of the literature. Arch Intern Med 1985; 145:58.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/30\" class=\"nounderline abstract_t\">Woo PC, Fung AM, Lau SK, et al. Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing. J Clin Microbiol 2001; 39:3147.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/31\" class=\"nounderline abstract_t\">Sylvetsky N, Raveh D, Schlesinger Y, et al. Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med 2002; 112:622.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/32\" class=\"nounderline abstract_t\">Cohen-Poradosu R, Jaffe J, Lavi D, et al. Group G streptococcal bacteremia in Jerusalem. Emerg Infect Dis 2004; 10:1455.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/33\" class=\"nounderline abstract_t\">Rantala S. Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection. Eur J Clin Microbiol Infect Dis 2014; 33:1303.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/34\" class=\"nounderline abstract_t\">Ekelund K, Skinh&oslash;j P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 2005; 11:569.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/35\" class=\"nounderline abstract_t\">Bucher A, Gaustad P. Septicemia and endocarditis caused by group G streptococci in a Norwegian hospital. Eur J Clin Microbiol Infect Dis 1990; 9:251.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/36\" class=\"nounderline abstract_t\">Rolston KV, Chandrasekar PH, LeFrock JL. Clinical features and antimicrobial therapy of infections caused by group G streptococci. Infection 1985; 13:203.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/37\" class=\"nounderline abstract_t\">Stein DS, Panwalker AP. Group C streptococcal endocarditis: case report and review of the literature. Infection 1985; 13:282.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/38\" class=\"nounderline abstract_t\">Schattner A, Vosti KL. Bacterial arthritis due to beta-hemolytic streptococci of serogroups A, B, C, F, and G. Analysis of 23 cases and a review of the literature. Medicine (Baltimore) 1998; 77:122.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/39\" class=\"nounderline abstract_t\">Gaunt PN, Seal DV. Group G streptococcal infection of joints and joint prostheses. J Infect 1986; 13:115.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/40\" class=\"nounderline abstract_t\">Ortel TL, Kallianos J, Gallis HA. Group C streptococcal arthritis: case report and review. Rev Infect Dis 1990; 12:829.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/41\" class=\"nounderline abstract_t\">Gonz&aacute;lez Ter&aacute;n B, Roiz MP, Ruiz Jimeno T, et al. Acute bacterial arthritis caused by group C streptococci. Semin Arthritis Rheum 2001; 31:43.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/42\" class=\"nounderline abstract_t\">Bronze MS, Whitby S, Schaberg DR. Group G streptococcal arthritis: case report and review of the literature. Am J Med Sci 1997; 313:239.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/43\" class=\"nounderline abstract_t\">Baddour LM, Bisno AL. Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise. Am J Med 1985; 79:155.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/44\" class=\"nounderline abstract_t\">Hilmarsd&oacute;ttir I, Valsd&oacute;ttir F. Molecular typing of Beta-hemolytic streptococci from two patients with lower-limb cellulitis: identical isolates from toe web and blood specimens. J Clin Microbiol 2007; 45:3131.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/45\" class=\"nounderline abstract_t\">Eriksson BK. Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity. Clin Infect Dis 1999; 29:1319.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/46\" class=\"nounderline abstract_t\">Hashikawa S, Iinuma Y, Furushita M, et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 2004; 42:186.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/47\" class=\"nounderline abstract_t\">Hirose Y, Yagi K, Honda H, et al. Toxic shock-like syndrome caused by non-group A beta-hemolytic streptococci. Arch Intern Med 1997; 157:1891.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/48\" class=\"nounderline abstract_t\">Cohen D, Ferne M, Rouach T, Bergner-Rabinowitz S. Food-borne outbreak of group G streptococcal sore throat in an Israeli military base. Epidemiol Infect 1987; 99:249.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/49\" class=\"nounderline abstract_t\">Stryker WS, Fraser DW, Facklam RR. Foodborne outbreak of group G streptococcal pharyngitis. Am J Epidemiol 1982; 116:533.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/50\" class=\"nounderline abstract_t\">Gerber MA, Randolph MF, Martin NJ, et al. Community-wide outbreak of group G streptococcal pharyngitis. Pediatrics 1991; 87:598.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/51\" class=\"nounderline abstract_t\">Fox K, Turner J, Fox A. Role of beta-hemolytic group C streptococci in pharyngitis: incidence and biochemical characteristics of Streptococcus equisimilis and Streptococcus anginosus in patients and healthy controls. J Clin Microbiol 1993; 31:804.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/52\" class=\"nounderline abstract_t\">Hayden GF, Murphy TF, Hendley JO. Non-group A streptococci in the pharynx. Pathogens or innocent bystanders? Am J Dis Child 1989; 143:794.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/53\" class=\"nounderline abstract_t\">Tartof SY, Farrimond F, de Matos JA, et al. Inverse association between Lancefield group G Streptococcus colonization and sore throat in slum and nonslum settings in Brazil. J Clin Microbiol 2011; 49:409.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/54\" class=\"nounderline abstract_t\">Turner JC, Fox A, Fox K, et al. Role of group C beta-hemolytic streptococci in pharyngitis: epidemiologic study of clinical features associated with isolation of group C streptococci. J Clin Microbiol 1993; 31:808.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/55\" class=\"nounderline abstract_t\">Kirby R, Ruoff KL. Cost-effective, clinically relevant method for rapid identification of beta-hemolytic streptococci and enterococci. J Clin Microbiol 1995; 33:1154.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/56\" class=\"nounderline abstract_t\">Sunaoshi K, Murayama SY, Adachi K, et al. Molecular emm genotyping and antibiotic susceptibility of Streptococcus dysgalactiae subsp. equisimilis isolated from invasive and non-invasive infections. J Med Microbiol 2010; 59:82.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/57\" class=\"nounderline abstract_t\">Ergin A, Ercis S, Has&ccedil;elik G. In vitro susceptibility, tolerance and MLS resistance phenotypes of Group C and Group G streptococci isolated in Turkey between 1995 and 2002. Int J Antimicrob Agents 2003; 22:160.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/58\" class=\"nounderline abstract_t\">Ip M, Lyon DJ, Leung T, Cheng AF. Macrolide resistance and distribution of erm and mef genes among beta-haemolytic streptococci in Hong Kong. Eur J Clin Microbiol Infect Dis 2002; 21:238.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/59\" class=\"nounderline abstract_t\">Brown DF, Hope R, Livermore DM, et al. Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008; 62 Suppl 2:ii75.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/60\" class=\"nounderline abstract_t\">Biedenbach DJ, Toleman MA, Walsh TR, Jones RN. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 2006; 55:119.</a></li><li><a href=\"https://www.uptodate.com/contents/group-c-and-group-g-streptococcal-infection/abstract/61\" class=\"nounderline abstract_t\">Kakuya F, Kinebuchi T, Okubo H, et al. Acute Pharyngitis Associated with Streptococcus dysgalactiae Subspecies equisimilis in Children. Pediatr Infect Dis J 2017.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3172 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H30585836\"><span>SUMMARY</span></a></li><li><a href=\"#H30585770\" id=\"outline-link-H30585770\">INTRODUCTION</a></li><li><a href=\"#H30585776\" id=\"outline-link-H30585776\">MICROBIOLOGY</a></li><li><a href=\"#H30585782\" id=\"outline-link-H30585782\">EPIDEMIOLOGY</a></li><li><a href=\"#H30585788\" id=\"outline-link-H30585788\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H30585794\" id=\"outline-link-H30585794\">Bacteremia</a></li><li><a href=\"#H30585800\" id=\"outline-link-H30585800\">Endocarditis</a></li><li><a href=\"#H30585806\" id=\"outline-link-H30585806\">Arthritis</a></li><li><a href=\"#H30585812\" id=\"outline-link-H30585812\">Skin and soft tissue infections</a></li><li><a href=\"#H30585818\" id=\"outline-link-H30585818\">Pharyngitis</a></li></ul></li><li><a href=\"#H30585824\" id=\"outline-link-H30585824\">DIAGNOSTIC EVALUATION</a></li><li><a href=\"#H30585830\" id=\"outline-link-H30585830\">TREATMENT</a></li><li><a href=\"#H30585836\" id=\"outline-link-H30585836\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/3172|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=ID/102608\" class=\"graphic graphic_algorithm\">- Approach to gram-positive cocci</a></li></ul></li><li><div id=\"ID/3172|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/68908\" class=\"graphic graphic_picture\">- Beta hemolysis 2</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antimicrobial-therapy-of-native-valve-endocarditis\" class=\"medical medical_review\">Antimicrobial therapy of native valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=infections-due-to-the-streptococcus-anginosus-streptococcus-milleri-group\" class=\"medical medical_review\">Infections due to the Streptococcus anginosus (Streptococcus milleri) group</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=necrotizing-soft-tissue-infections\" class=\"medical medical_review\">Necrotizing soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-streptococcal-pharyngitis\" class=\"medical medical_review\">Treatment and prevention of streptococcal pharyngitis</a></li></ul></div></div>","javascript":null}